Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct 7;111(40):14518-23.
doi: 10.1073/pnas.1215767111. Epub 2014 Sep 22.

MicroRNA-223 coordinates cholesterol homeostasis

Affiliations

MicroRNA-223 coordinates cholesterol homeostasis

Kasey C Vickers et al. Proc Natl Acad Sci U S A. .

Abstract

MicroRNAs (miRNAs) regulate a wide variety of biological processes and contribute to metabolic homeostasis. Here, we demonstrate that microRNA-223 (miR-223), an miRNA previously associated with inflammation, also controls multiple mechanisms associated with cholesterol metabolism. miR-223 promoter activity and mature levels were found to be linked to cellular cholesterol states in hepatoma cells. Moreover, hypercholesterolemia was associated with increased hepatic miR-223 levels in athero-prone mice. miR-223 was found to regulate high-density lipoprotein-cholesterol (HDL-C) uptake, through direct targeting and repression of scavenger receptor BI, and to inhibit cholesterol biosynthesis through the direct repression of sterol enzymes 3-hydroxy-3-methylglutaryl-CoA synthase 1 and methylsterol monooxygenase 1 in humans. Additionally, miR-223 was found to indirectly promote ATP-binding cassette transporter A1 expression (mRNA and protein) through Sp3, thereby enhancing cellular cholesterol efflux. Finally, genetic ablation of miR-223 in mice resulted in increased HDL-C levels and particle size, as well as increased hepatic and plasma total cholesterol levels. In summary, we identified a critical role for miR-223 in systemic cholesterol regulation by coordinated posttranscriptional control of multiple genes in lipoprotein and cholesterol metabolism.

Keywords: atherosclerosis; posttranscriptional gene regulation; reverse cholesterol transport.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
miR-223 expression is linked to cholesterol. (A) miR-223 and miR-33 changes with cholesterol depletion (10% lipoprotein-depleted serum, LPDS) in Huh7 cells, as determined by real-time PCR. n = 5–6. h, hours. Mann–Whitney nonparametric tests. (B and C) Simvastatin (5 µM), cholesterol depletion (10% LPDS), LDL (100 µg/mL) treatments in J774 and Huh7 cells for 24 h. (B) miR-223 levels in J774 and Huh7 cells; n = 5. (C) miR-223 promoter activity. miR-223 promoter driving secretory Gaussia luciferase activity, which was normalized to secreted alkaline phosphatase for transfection control. Ratios are reported as fold change to FBS conditions; n = 6, Mann–Whitney nonparametric test. LPDS (lipoprotein-depleted serum) was switched to FBS at 24 h. (D) Total cholesterol levels in liver of apolipoprotein E-null mice (Apoe−/−) mice on chow diet for 4 wk compared with wild-type (WT), as determined by total cholesterol colorimetric assays; n = 4. (E) Hepatic miR-223 levels in Apoe−/− mice fed chow diet for 4 wk, as determined by real-time PCR; n = 3–4. (F) Total cholesterol levels in livers of Apoe−/− mice on cocoa butter diet (CBD) for 4 wk, as determined by total cholesterol colorimetric assays; n = 4. (G) Hepatic miR-223 levels in Apoe−/− mice fed CBD for 4 wk, as determined by real-time PCR; n = 4. (H) Hepatic Hmgcr, Hmgcs1, Sp3, Abca1, and Scarb1 (SR-BI) mRNA levels in Apoe−/− mice on CBD for 4 wk, as determined by real-time PCR; n = 4. Data are mean ± SEM. Mann–Whitney nonparametric tests. *P < 0.05, **P < 0.0001.
Fig. 2.
Fig. 2.
miR-223 represses HDL-cholesterol uptake. (A) SR-BI mRNA levels with miR-223 overexpression and inhibition (hairpin inhibitor against miR-223, HI-223) in Huh7 cells (100 nM), as determined by real-time PCR. Control miR-151 (n = 4), control siRNA (n = 8), miR-223 (n = 14), siRNA SR-BI (n = 8), and HI-223 (n = 3) 100 nM. One-way analysis of variance with Newman–Keuls Multiple Comparison Post-Test. (B) ABCA1 and SR-BI protein levels in Huh7 cells after miR-223 or control miR-455-3p overexpression at 48 h and 72 h, as determined by Western blots. (C) Gene reporter (luciferase) assays in HEK293 cells. SR-BI 3′ UTR luciferase reporter (500 ng). Shown is plus or minus 3-base deletion in the predicted miR-223 target site; 50 nM miR-223 mimetic. Firefly luciferase (FL) normalized to transfection control Renilla luciferase (RL); n = 3–9. Mann–Whitney nonparametric test. (D) HDL-C [3H-cholesteryl ester (CE)] uptake reported as fold change uptake in Huh7 cells. miR-223, siRNA SR-BI, or control miR-455-3p (100 nM); n = 3. Unpaired Student t test. *P < 0.05, **P < 0.0001.
Fig. 3.
Fig. 3.
miR-223 inhibits cholesterol biosynthesis. (A) Shown are 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1) mRNA levels in Huh7 cells. Mock n = 4, control miRNA n = 4, miR-223 n = 4, and hairpin inhibitor-223 (HI-223) n = 4. One-way analysis of variance with Newman–Keuls Multiple Comparison Post-Test. (B) Methylsterol monooxygenase 1 (SC4MOL) mRNA levels in Huh7 cells. Mock n = 3, control miRNA n = 3, miR-223 n = 3, and hairpin inhibitor-223 (HI-223) n = 3. Unpaired t test. (C) Gene reporter (luciferase) assays in HEK293 cells. HMGCS1 3′ UTR luciferase reporter (500 ng). Plus or minus 3-base deletion in the predicted miR-223 target site (500 ng); 50 nM miR-223 mimetic. Firefly luciferase (FL) normalized to transfection control Renilla luciferase (RL); n = 6; Mann–Whitney nonparametric test. (D) Cholesterol biosynthesis in Huh7 cells, as determined by radiolabeled (3H-acetic acid) acetate incorporation assays. Control miR-106a n = 6 and miR-223 n = 5. Mann–Whitney nonparametric test. Data are mean ± SEM; *P < 0.05, **P < 0.01.
Fig. 4.
Fig. 4.
miR-223 promotes cholesterol efflux through ABCA1. (A) ABCA1 mRNA levels in Huh7 cells, as quantified by real-time PCR. Mock n = 6, control miR-151 n = 6, and miR-223 n = 9. Mann–Whitney nonparametric tests. (B) Cholesterol efflux to apoA-I (10 µg/mL) in Huh7 cells. Mock n = 11 and miR-223 n = 12. Percent efflux [media counts/total counts (media plus cell lysates)] reported as fold change Mann–Whitney nonparametric tests. (C) Sp3 transcription factor mRNA levels in Huh7 cells, as determined by microarray (Mock n = 6, miR-223 n = 6) and real-time PCR analysis [Mock n = 7, miR-223 n = 7, and hairpin inhibitor (HI-223) n = 7]. Mann–Whitney nonparametric tests. One-way analysis of variance with Newman–Keuls Multiple Comparison Post-Test. (D) Gene reporter (luciferase) assays in HEK293 cells. Sp3 3′ UTR luciferase reporter (500 ng). Firefly-Sp3 3′ UTR reporter with 2-base deletion in the predicted miR-223 target site (500 ng); 1 nM miR-223 mimetic. Firefly luciferase (FL) normalized to transfection control Renilla luciferase (RL); n = 21. Mann–Whitney nonparametric test. (E) Nuclear Sp3 transcriptional activity in Huh7 cells, as determined by Sp3 transcription factor binding assays. Mock n = 4, siRNA Sp3 n = 2, miR-223 n = 4, hairpin inhibitor miR-223 (HI-223) n = 3. Mann–Whitney nonparametric tests. (F) miR-223 expression after siRNA knockdown of Sp3 in Huh7 cells, as quantified by real-time PCR. Mock n = 6 and siRNA Sp3 n = 6. Mann–Whitney nonparametric tests. (G) Schematic of miR-223 efflux regulation. Data are mean ± SEM. *P < 0.05, **P < 0.0001.
Fig. 5.
Fig. 5.
miR-223 controls cholesterol homeostasis in vivo. (A) Significant differential gene (mRNA) expression changes in miR-223−/− livers compared with wild-type (WT) controls. Benjamini–Hochberg false discovery rate corrected P < 0.05; absolute fold change > 1.5; n = 6. Volcano plot illustrating significant down-regulated and up-regulated genes (black dots). (B) Plasma total cholesterol (mg/dL) in miR-223−/− and WT mice. WT n = 4, miR-223−/− n = 21. Mann–Whitney nonparametric tests. (C) Fast Protein Liquid Chromatography profile of total cholesterol (mg/dL) from WT and miR-223−/− mice. Pooled samples for each condition. (D and E) Colorimetric cholesterol assays on lipids extracted from miR-223−/− and WT mouse livers; mg/dL reported as fold change; n = 9–10; Mann–Whitney Nonparametric test. (D) Total cholesterol, (E) free cholesterol, and (F) cholesteryl ester. (G) Schematic of miR-223 targets and regulatory modules associated with cholesterol metabolism. Cholesterol biosynthesis intermediates: a, acetoacetyl-CoA; b, beta-hydroxy-beta-methylglutaryl-CoA; c, 4,4-dimethylcholesta-8(9),24-dien-3beta-ol; d, 4-methyl,4-carboxycholesta-8(9) 24-dien-3beta-ol. Data are mean ± SEM. *P < 0.05.

Comment in

Similar articles

Cited by

References

    1. Espenshade PJ, Hughes AL. Regulation of sterol synthesis in eukaryotes. Annu Rev Genet. 2007;41:401–427. - PubMed
    1. Brown MS, Goldstein JL. Sterol regulatory element binding proteins (SREBPs): Controllers of lipid synthesis and cellular uptake. Nutr Rev. 1998;56(2 Pt 2):S1–S3, discussion S54–S75. - PubMed
    1. Cuchel M, et al. Pathways by which reconstituted high-density lipoprotein mobilizes free cholesterol from whole body and from macrophages. Arterioscler Thromb Vasc Biol. 2010;30(3):526–532. - PMC - PubMed
    1. Ishibashi S, et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. 1993;92(2):883–893. - PMC - PubMed
    1. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. - PubMed

Publication types